Skip Navigation

European Heart Journal 1998 19(6):936-942; doi:10.1053/euhj.1997.0860
Copyright © 1998 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lindinger, A.
Right arrow Articles by Hoffmann, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindinger, A.
Right arrow Articles by Hoffmann, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Permanent junctional re-entry tachycardia. A multicentre long-term follow-up study in infants, children and young adults

A. Lindingeraf1, A. Heiselb, G. von Bernuthc, T. Pauld, H. Ulmere, W. Kienastf, H. Pitschnerg, K. Kuckh and W. Hoffmanna

a Department of Pediatric Cardiology, University Children’s Hospital, Homburg/Saar, Germany
b Department of Cardiology of the University, Homburg/Saar, Germany
c Department of Pediatric Cardiology, University Children’s Hospital, Aachen, Germany
d Department of Pediatric Cardiology, University Children’s Hospital, Hannover, Germany
e Department of Pediatric Cardiology, University Children’s Hospital, Heidelberg, Germany
f Department of Pediatric Cardiology, University Children’s Hospital, Rostock, Germany
g Department of Cardiology, W.G. Kerckhoff-Clinic, Bad Nauheim, Germany
h Department of Cardiology, AK St. Georg, Hamburg, Germany

accepted November 21, 1997

Aims

Permanent junctional re-entry tachycardia is a relatively uncommon form of re-entry tachycardia with antegrade conduction occurring through the atrioventricular node and retrograde conduction over an accessory pathway usually located in the postero-septal region. It was the aim of the study to investigate the course of permanent junctional re-entry tachycardia with particular regard to the effectiveness of pharmacological treatment and ablation procedures; evaluation was performed with respect to the patient’s symptoms, tachycardia rate, frequency of the tachycardia and left ventricular function.

Methods and Results

The long-term follow-up of 32 patients with permanent junctional re-entry tachycardia was evaluated. The first presentation with supraventricular tachycardia occurred between the 27th week of gestation and 27 years. The tachycardia rate ranged from 100 to 250 beats.min–1. During Holter-ECG, permanent junctional re-entry tachycardia was documented as present for over 50% of the time in 24h in 22 patients (69%). Left ventricular performance was impaired in nine patients (28%) due to a tachycardia-related cardiomyopathy. Symptoms or signs of heart failure were mild to moderate in eight and severe in four patients; 20 patients showed no clinical impairment. Follow-up time was 1 to 31 (mean 10) years; current age of the patients ranged from 1·5 months to 35 (mean=15·3) years. Four patients needed no therapy because of the infrequency of permanent junctional re-entry tachycardia episodes. Twenty-five patients initially received antiarrhythmic drugs, which were effective or partially effective in 14 (56%). Eight of them are still on medical therapy; in five treatment was discontinued because of absence of symptoms. Eleven patients had ablation of the accessory pathway during follow-up, three underwent ablation as a primary procedure.

Conclusion

Permanent junctional re-entry tachycardia in our experience is an arrhythmia with a large variety of clinical symptoms. Patients with a slow tachycardia rate and infrequent episodes of tachycardia may never develop symptoms and therefore do not need any therapy. Patients with frequent permanent junctional re-entry tachycardia, a fast tachycardia rate and impaired left ventricular function need effective therapy. In infancy and early childhood medical therapy is recommended as a first option, whereas in older and symptomatic patients catheter ablation is an effective and safe procedure.

Key Words: permanent junctional re-entry tachycardia • catheter ablation • PJRT long-term follow-up • childhood/adolescence

f1 Correspondence: Angelika Lindinger, MD, Department of Pediatric Cardiology, University Children’s Hospital, D-66421 Homburg/Saar, Germany.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
EuropaceHome page
A. Meiltz, R. Weber, F. Halimi, P. Defaye, S. Boveda, R. Tavernier, D. Kalusche, and M. Zimmermann
Permanent form of junctional reciprocating tachycardia in adults: peculiar features and results of radiofrequency catheter ablation.
Europace, January 1, 2006; 8(1): 21 - 28.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G Vaksmann, C D'Hoinne, V Lucet, S Guillaumont, J-M Lupoglazoff, A Chantepie, I Denjoy, E Villain, and F Marcon
Permanent junctional reciprocating tachycardia in children: a multicentre study on clinical profile and outcome
Heart, January 1, 2006; 92(1): 101 - 104.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. F. Price, N. J. Kertesz, C. S. Snyder, R. A. Friedman, and A. L. Fenrich Jr
Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age
J. Am. Coll. Cardiol., February 6, 2002; 39(3): 517 - 520.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.